• Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Norway

dkNET community events and announcements in February, 2019

dkNET community events and announcements in February, 2019

Dear dkNET Community,

dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.


Events in February, 2019

Feb. 1, 2019

Abstract deadline: 3rd Joint EASD Islet Study Group and Beta-Cell Workshop 

The ethos of the meeting is to bring together basic and clinical scientists from all over the world working on all aspects of the beta-cell (and other islet cells) from their birth to their demise. It is an opportunity to hear from the Rising Stars and outstanding experts in the field and to provide plenty of opportunities for scientific discussion and networking.
Location: London, UK

Feb. 3-8, 2019 

Gordon Research Conference: Understanding Human Diseases Through Metabolomics: Interactions Among the Genome, Proteome, Gut Microbiome and Nutrition

In this Gordon Conference series, we highlight state of the art metabolomics technologies and their applications to the study of human health and disease. We will cover most recent developments in the field covering applications of metabolomics for deeper understanding of disease mechanisms, disease heterogeneity and disease progression; variation in treatment outcomes and enablement of precision medicine approaches; connections between metabolome, proteome and genome and atlases being created; effects of exposome, diet and gut microbiome on human metabolome and health. We will highlight large consortia initiatives which enable epidemiology and clinical studies, functional genomics, nutrigenomics, pharmaceutical applications including toxicology studies, systems pharmacology, environmental exposures effects on health (exposome) and beyond. We invite established as well as early career members to attend this meeting from academia industry and regulatory agencies.

Location: Ventura, CA, USA 

More information:  https://www.grc.org/metabolomics-and-human-health-conference/2019/

Feb. 10-14, 2019

Keystone Symposia: Functional Neurocircuitry of Feeding and Feeding Disorders (J8) 

Location: Banff Springs, Banff, Alberta, Canada

    More information:  https://www.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1633


    Feb. 10-14, 2019 

    Keystone Symposia: Obesity and Adipose Tissue Biology (J7) 

    Location: Banff, AB, Canada

    More information:  https://www.keystonesymposia.org/index.cfm?e=web.meeting.program&meetingid=1632


    Feb. 13-15, 2019 

    Alberta British Columbia Islet Workshop 2019 

    Joint with the meeting on Cellular Plasticity: Reprogramming, Regeneration and Metaplasia (J3).

    Location: Silver Star Mountain, British Columbia

    More information: https://diabetesbc.ca/our-events/alberta-british-columbia-islet-workshop-2019


    Feb. 20 -22, 2019 

    The ISSCR International Symposia: Stem Cells & Organoids in Development & Disease 

    Stem Cells & Organoids in Development & Disease offers three days of insightful presentations and conversations around a research topic at the forefront of our field. Renowned keynote speakers Hans Clevers and Jürgen Knoblich will give the opening and closing talks; in between, hear from invited experts from around the globe, and abstract-selected speakers presenting their latest research.

    Location: Amsterdam, Netherlands

    More information: http://www.isscr.org/meetings-events/international-symposia/amsterdam-2019-symposium

    Feb. 22-24, 2019 

    10th International Conference on Bioinformatics Models, Methods and Algorithms 

    The purpose of the International Conference on Bioinformatics Models, Methods and Algorithms is to bring together researchers and practitioners interested in the design and application of modelling frameworks, algorithmic concepts, computational methods, and information technologies to address challenging problems in Bioinformatics and Biomedical research.There is a tremendous need to explore how mathematical, statistical and computational techniques can be used to better understand biological processes and systems, while developing new methodologies and tools to analyze the massive currently-available biological data. Areas of interest to this community include systems biology and biological networks (regulatory, neuronal, predator-prey, ecological ones, etc.), sequence analysis, biostatistics, graph models, image analysis, scientific data management and data mining, machine learning, pattern recognition, computational evolutionary biology, computational genomics and proteomics, and related areas.

    Location: Prague, Czech Republic

    More information: http://www.bioinformatics.biostec.org

    Feb. 28, 2019 

    Submission deadline: The KidneyX - Redesign Dialysis Prize Challenge

    The KidneyX: Redesign Dialysis prize challenge aims to accelerate the development and commercialization of next-generation dialysis products. Applications are currently being accepted for Phase 1 of the prize competition that focuses on designs of solutions, including components of solutions, in many areas of improving the lives of people with kidney diseases.

    More information: http://www.kidneyx.org


    Funding opportunities information and deadlines in February, 2019


    Feb. 21, 2019 

    NIDDK Funding Opportunity Letter of Intent Due Date: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)  
    This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications for funding to perform research leading to the development of novel and supportive technologies for the improvement of cell replacement interventions using novel methods, biomaterials and devices for type 1 diabetes (T1D) treatment.

    More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-023.html


    Feb. 26, 2019 

    NIDDK Funding Opportunity Application Due Date: Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)

    This Funding Opportunity Announcement (FOA) solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment. CTAR is part of the Human Islet Research Network (HIRN).

    More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-014.html


    Feb. 26, 2019 

    NIDDK Funding Opportunity Application Due Date: Human Pancreas Analysis Program (HPAP) (U01 Clinical Trial Not Allowed)
    This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to continue the mission of the existing Human Pancreas Analysis Program (HPAP). This FOA will support one team of investigators with combined expertise in human pancreas physiology and pathophysiology; collection, processing and multimodal analysis of human pancreatic tissues; and biological database building, curation and management, that will be tasked to: 1) identify, collect and intensively characterize primary pancreatic tissues from patients with type 1 diabetes (T1D), beta cell specific autoimmunity, or rare forms of islet dysfunction that may inform understanding of the pathogenesis of T1D , as well as age-matched controls; and 2) analyze, organize and share the data resulting from the study of these tissues and expand the existing PANC DB open-access resource database. HPAP is a component of HIRN, created in 2014 to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional human beta cell mass.

    More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-015.html


    Feb. 26, 2019 

    NIDDK Funding Opportunity Application Due Date: Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
    This Funding Opportunity Announcement (FOA) invites cooperative agreement applications to expand the operational scope of the existing Human Pancreas Analysis Program (HPAP) to the study of pancreata recovered from tissue donors with Type 2 Diabetes (T2D) and related metabolic disorders. This FOA will support one team of investigators with combined expertise in human pancreas physiology and pathophysiology; collection, processing and multimodal analysis of human pancreatic tissues; and biological database building, curation and management, with a program goal of further advancing research through a shared resource, by tasking the team with : 1) identifying, collecting and intensively characterizing primary pancreatic tissues from patients with T2D and related forms of islet dysfunction, as well as age-matched controls; and 2) analyzing, organizing and sharing the data resulting from the study of these tissues through use and expansion of the existing PANC DB open-access resource database. HPAP is a component of the Human Islet Research Network (HIRN), created in 2014 to support innovative and collaborative translational research to understand how human beta cells are lost in Type 1 Diabetes (T1D), and to find innovative strategies to protect and replace functional human beta cell mass.

    More information:  https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-016.html



    X

    Are you sure you want to delete that component?